Robert T O'Donnell, MD; PhD


  • 2554 Citations
  • 29 h-Index
1979 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Robert T O'Donnell is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Radioimmunotherapy Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Antibodies Medicine & Life Sciences
Monoclonal Antibodies Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Yttrium Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1979 2019

  • 2554 Citations
  • 29 h-Index
  • 89 Article
  • 1 Letter
Acute Myeloid Leukemia
liposomal doxorubicin
2 Citations (Scopus)

A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma

El-Khoueiry, A. B., O'Donnell, R. T., Semrad, T., Mack, P., Blanchard, S., Bahary, N., Jiang, Y., Yen, Y., Wright, J., Chen, H., Lenz, H. J. & Gandara, D. R., Mar 8 2018, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology. p. 1-7 7 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Liver Neoplasms
2 Citations (Scopus)

A purified, fermented, extract of Triticum aestivum has lymphomacidal activity mediated via natural killer cell activation

Barisone, G., O'Donnell, R. T., Ma, Y., Abuhay, M. W., Lundeberg, K., Gowda, S. & Tuscano, J., Jan 1 2018, In : PLoS One. 13, 1, e0190860.

Research output: Contribution to journalArticle

wheat germ
natural killer cells
non-Hodgkin lymphoma
Natural Killer Cells
Non-Hodgkin's Lymphoma
4 Citations (Scopus)

The HB22.7–vcMMAE antibody–drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity

Abuhay, M., Kato, J., Tuscano, E., Barisone, G., Sidhu, R. S., O'Donnell, R. T. & Tuscano, J., Oct 1 2016, In : Cancer Immunology, Immunotherapy. 65, 10, p. 1169-1175 7 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Sulfhydryl Compounds
Cell Line
B-Cell Lymphoma
2 Citations (Scopus)

Efficacy of combined histone deacetylase and checkpoint kinase inhibition in a preclinical model of human Burkitt lymphoma

Kong, Y. G., Barisone, G., Sidhu, R. S., O'Donnell, R. T. & Tuscano, J., Aug 24 2015, In : Molecular Medicine. 21, p. 824-832 9 p.

Research output: Contribution to journalArticle

Histone Deacetylases
Burkitt Lymphoma
Histone Deacetylase Inhibitors
Checkpoint Kinase 2